GSK to dispose the 2.5% stake in Haleon.

Financials

Edit Data

Transaction Value-

Consideration TypeCash

Capital Owned13%

Capital Bid For3%

EV/Sales-

EV/EBITDA-

Share Price Premium-

One Off Charge-

target

HALEON

bidder

Institutional Investors

vendor

Glaxosmithkline

Sources

Edit

Tags

Edit

Public

Minority

Pharmaceuticals

pharmaceutical

healthcare

United Kingdom

Acquisition

Domestic

Disposal

Pending

Friendly

Single Bidder

Synopsis

Edit

GSK, a multinational pharmaceutical and biotechnology company, agreed to dispose the 2.5% stake in Haleon, a consumer healthcare company. Financial terms were not disclosed.

GSK to dispose the 2.5% stake in Haleon.

target

bidder

vendor

legal advisors